Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas C P Cross

Showing results (31-40 of 221) with videos related to

Pageof 23
Sort By:
Nucleic Acids Research|March 18, 2015
Identification of U2AF(35)-dependent exons by RNA-Seq reveals a link between 3' splice-site organization and activity of U2AF-related proteinsJana Kralovicova, Marcin Knut, Nicholas C P Cross, et al.
Haematologica|August 10, 2012
Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndromeAndrew Chase, Catherine Bryant, Joannah Score, et al.
Leukemia & Lymphoma|March 21, 2017
Evaluation of serum erythropoietin values as defined by 2016 World Health Organization criteria for the diagnosis of polycythemia veraRichard T Silver, Spencer Krichevsky, Stefani Gjoni, et al.
Science Advances|April 21, 2023
Age-related loss of chromosome Y is associated with levels of sex hormone binding globulin and clonal hematopoiesis defined by <i>TET2</i>, <i>TP53</i>, and <i>CBL</i> mutationsAhmed A Z Dawoud, William J Tapper, Nicholas C P Cross
Leukemia|June 11, 2020
Clonal myelopoiesis in the UK Biobank cohort: ASXL1 mutations are strongly associated with smokingAhmed A Z Dawoud, William J Tapper, Nicholas C P Cross
Leukemia|October 6, 2021
HGNC nomenclature for fusion genesRobert Peter Gale, Andreas Hochhaus, Nicholas C P Cross, et al.
Cells|July 12, 2020
EZH2 in Myeloid MalignanciesJenny Rinke, Andrew Chase, Nicholas C P Cross, et al.
Leukemia Research|May 22, 2007
International standardisation of quantitative real-time RT-PCR for BCR-ABLNicholas C P Cross, Timothy P Hughes, Andreas Hochhaus, et al.
Leukemia Research|June 29, 2005
NUP98-LEDGF fusion and t(9;11) in transformed chronic myeloid leukemiaFrancis H Grand, Prasad Koduru, Nicholas C P Cross, et al.
Acta Haematologica|February 3, 2018
Routine Screening for KIT M541L Is Not Warranted in the Diagnostic Work-Up of Patients with HypereosinophiliaYvette Hoade, Georgia Metzgeroth, Juliana Schwaab, et al.
Pageof 23

Showing results (31-40 of 221) with videos related to

Sort By:
Pageof 23
Nucleic Acids Research|March 18, 2015
Identification of U2AF(35)-dependent exons by RNA-Seq reveals a link between 3' splice-site organization and activity of U2AF-related proteinsJana Kralovicova, Marcin Knut, Nicholas C P Cross, et al.
Haematologica|August 10, 2012
Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndromeAndrew Chase, Catherine Bryant, Joannah Score, et al.
Leukemia & Lymphoma|March 21, 2017
Evaluation of serum erythropoietin values as defined by 2016 World Health Organization criteria for the diagnosis of polycythemia veraRichard T Silver, Spencer Krichevsky, Stefani Gjoni, et al.
Science Advances|April 21, 2023
Age-related loss of chromosome Y is associated with levels of sex hormone binding globulin and clonal hematopoiesis defined by <i>TET2</i>, <i>TP53</i>, and <i>CBL</i> mutationsAhmed A Z Dawoud, William J Tapper, Nicholas C P Cross
Leukemia|June 11, 2020
Clonal myelopoiesis in the UK Biobank cohort: ASXL1 mutations are strongly associated with smokingAhmed A Z Dawoud, William J Tapper, Nicholas C P Cross
Leukemia|October 6, 2021
HGNC nomenclature for fusion genesRobert Peter Gale, Andreas Hochhaus, Nicholas C P Cross, et al.
Cells|July 12, 2020
EZH2 in Myeloid MalignanciesJenny Rinke, Andrew Chase, Nicholas C P Cross, et al.
Leukemia Research|May 22, 2007
International standardisation of quantitative real-time RT-PCR for BCR-ABLNicholas C P Cross, Timothy P Hughes, Andreas Hochhaus, et al.
Leukemia Research|June 29, 2005
NUP98-LEDGF fusion and t(9;11) in transformed chronic myeloid leukemiaFrancis H Grand, Prasad Koduru, Nicholas C P Cross, et al.
Acta Haematologica|February 3, 2018
Routine Screening for KIT M541L Is Not Warranted in the Diagnostic Work-Up of Patients with HypereosinophiliaYvette Hoade, Georgia Metzgeroth, Juliana Schwaab, et al.
Pageof 23